5Labate A, Colosimo E, Gambardella A, et al. Levetiracetam in Patients with Generalized Epilepsy and Myoclonic Seizures: an Open Label Study[J]. Seizure (SI059 - 1311), 2006,15(3) :214-218.
6Zona C, Niespodziany I, Marchetti C, et al. Levetiracetam Does Notmodulate Neuronal Voltage-gated Na^+ and T-type Ca^2+ Currents[J].Seizure(S1059 - 1311) ,2001,10(4) :279-286.
7Lynch BA, Lambeng N, Nocka K, et al. The Synaptic Vesicle Protein SV2A Is the Binding Site for the Antiepileptic Drug Levetiracetam[J]. Proc Natl Acad Sci U S A(S0027-8424),2004,101(26) :9861-9866.
8Custer KL, Austin NS, Sullivan JM, et al. Synaptic Vesicle Protein 2 Enhances Release Probability at Quiescent Synapses[J]. J Neurosci (S1529 - 2401 ), 2006,26(4) : 1303- 1313.
9Growdre KM, Gunther JM, Jones TA, et al. Abnormal Neurotransmission in Mice Lacking Synaptic Vesicle Protein 2A (SV2A)[J]. Proc Natl Acad Sci U S A (S0027- 8424), 1999,96 (26) : 15268- 15273.
10Steinhoff BJ, Trink E, Wieser HG, et al. Levetiracetam in Patients with Refractory Epilepsy: Results of the SKATE Trial in Austria, Germany and Switzerland[J].Seizure (S1059 - 1311 ), 2005, 14 (7):490 - 496.
